Similar articles

• [1st immunologic attempts in the treatment of human malignant tumors].

  Mannelli MA. Mannelli MA. Minerva Med. 1977 Apr 21;68(19):1301-4. Minerva Med. 1977. PMID: 854230 Italian. No abstract available.
• The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.

  DelVillano BC, Zurawski VR Jr. DelVillano BC, et al. Lab Res Methods Biol Med. 1983;8:269-82. Lab Res Methods Biol Med. 1983. PMID: 6196588 No abstract available.
• Bi-specific antibody therapy for the treatment of cancer.

  Withoff S, Helfrich W, de Leij LF, Molema G. Withoff S, et al. Curr Opin Mol Ther. 2001 Feb;3(1):53-62. Curr Opin Mol Ther. 2001. PMID: 11249732 Review.
• Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.

  Bodey B, Siegel SE, Kaiser HE. Bodey B, et al. Anticancer Res. 1996 Mar-Apr;16(2):661-74. Anticancer Res. 1996. PMID: 8687112 Review.
• Tumor-associated antigens and biomarkers in cancer and immune therapy.

  Malyankar UM. Malyankar UM. Int Rev Immunol. 2007 May-Aug;26(3-4):223-47. doi: 10.1080/08830180701402496. Int Rev Immunol. 2007. PMID: 17558745 Review.